Table 1.
Incidence of visceral and soft tissue sarcoma and tumors of intermediate malignancy over the 4 years of the study.
Table 2.
Incidence of bone sarcoma over the 4 years of the study.
Table 3.
Incidence of uterine and rare bone sarcoma over the 4 years of the study.
Fig 1.
Published clinical trials in sarcoma and TIM histotypes.
The histograms present the percentage of sarcoma histotypes and groups of histotypes with published clinical trials in Pubmed according to the incidence of the histotypes (>1/106/year vs <1/106/year). Numbers of histotypes with published phase III clinical trials (left), randomized phase II trials (center), and phase II trials (right) are indicated, with chi square p value for the comparison between the 2 incidence groups (>1/106/year vs <1/106/year). Histotypes were considered individually (e.g. monophasic synovial sarcoma) or globally (e.g. all synovial sarcoma).
Table 4.
Clinical characteristics of individual sarcoma histotypes.